1. Home
  2. RYTM vs PBF Comparison

RYTM vs PBF Comparison

Compare RYTM & PBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • PBF
  • Stock Information
  • Founded
  • RYTM 2008
  • PBF 2008
  • Country
  • RYTM United States
  • PBF United States
  • Employees
  • RYTM N/A
  • PBF N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • PBF Integrated oil Companies
  • Sector
  • RYTM Health Care
  • PBF Energy
  • Exchange
  • RYTM Nasdaq
  • PBF Nasdaq
  • Market Cap
  • RYTM 3.8B
  • PBF 3.1B
  • IPO Year
  • RYTM 2017
  • PBF 2012
  • Fundamental
  • Price
  • RYTM $57.38
  • PBF $20.15
  • Analyst Decision
  • RYTM Strong Buy
  • PBF Hold
  • Analyst Count
  • RYTM 12
  • PBF 13
  • Target Price
  • RYTM $75.42
  • PBF $23.92
  • AVG Volume (30 Days)
  • RYTM 671.0K
  • PBF 3.2M
  • Earning Date
  • RYTM 05-07-2025
  • PBF 05-01-2025
  • Dividend Yield
  • RYTM N/A
  • PBF 5.46%
  • EPS Growth
  • RYTM N/A
  • PBF N/A
  • EPS
  • RYTM N/A
  • PBF N/A
  • Revenue
  • RYTM $136,863,000.00
  • PBF $31,536,100,000.00
  • Revenue This Year
  • RYTM $43.84
  • PBF N/A
  • Revenue Next Year
  • RYTM $65.62
  • PBF $7.29
  • P/E Ratio
  • RYTM N/A
  • PBF N/A
  • Revenue Growth
  • RYTM 48.88
  • PBF N/A
  • 52 Week Low
  • RYTM $35.17
  • PBF $13.62
  • 52 Week High
  • RYTM $68.58
  • PBF $51.70
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 43.00
  • PBF 65.79
  • Support Level
  • RYTM $62.69
  • PBF $18.05
  • Resistance Level
  • RYTM $65.53
  • PBF $19.32
  • Average True Range (ATR)
  • RYTM 3.04
  • PBF 0.91
  • MACD
  • RYTM -0.73
  • PBF 0.59
  • Stochastic Oscillator
  • RYTM 1.14
  • PBF 94.09

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About PBF PBF Energy Inc.

PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.

Share on Social Networks: